Andere Sprachen Black Diamond Therapeutics, Inc.

Aktien

A2PYWB

US09203E1055

BDTX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
5,89 ^USD	+15,26 %		+11,98 %	+109,61 %

11.04.	Black Diamond Therapeutics, Inc. gibt Änderungen im Vorstand und in den Ausschüssen bekannt	CI
08.04.	BLACK DIAMOND THERAPEUTICS, INC. : Bewertung von Wedbush kaufen	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24.04.
Black Diamond Therapeutics, Inc. Announces Board and Committee Changes	11.04.
Black Diamond Therapeutics Announces Changes to Board of Directors	11.04.
Black Diamond Therapeutics Says BDTX-1535 Potentially Inhibits Non-Classical Mutations in Non-Small Cell Lung Cancer Patients	08.04.
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting	08.04.
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting	08.04.
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences	03.04.
Black Diamond: Q4 Earnings Snapshot	12.03.
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	12.03.
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	12.03.
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12.03.
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12.03.
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024	05.03.
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	28.02.
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	28.02.
Black Diamond Therapeutics, Inc. Announces Resignation of Rajeev Shah from Board of Directors, Including as A Member of the Audit Committee of the Board	18.01.
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones	04.01.
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones	04.01.
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM	13.12.
Black Diamond Therapeutics, Inc. Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM	13.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Black Diamond Therapeutics, Inc.

Aktien

A2PYWB

US09203E1055

BDTX

Andere Sprachen

Filter